Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension
Journal of Veterinary Internal Medicine · 2023
DOI: 10.1111/jvim.16686 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2023. Written by Yunosuke Yuchi and 6 co-authors. Institution: Laboratory of Veterinary Internal Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science Universi…. Major MEDLINE topics: Hypertension, Pulmonary, Tricuspid Valve Insufficiency, Atrial Fibrillation, Dog Diseases. Cited 8 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Japan Society for the Promotion of Science.
Abstract (original language)
Background
Progression to combined post- and pre-capillary pulmonary hypertension (PH) provides prognostic information in human patients with post-capillary PH. Pulmonary vascular resistance estimated by echocardiography (PVRecho) is useful for the stratification of dogs with myxomatous mitral valve disease (MMVD) and detectable tricuspid regurgitation.
Objectives
To evaluate the prognostic value of PVRecho in dogs with MMVD. Animals Fifty-four dogs with MMVD and detectable tricuspid regurgitation.
Methods
Prospective cohort study. All dogs underwent echocardiography. The PVRecho was calculated based on tricuspid regurgitation and the velocity-time integral of the pulmonary artery flow. To evaluate the influence of echocardiographic variables on cardiac-related deaths, Cox proportional hazard analysis was performed. Additionally, Kaplan-Meier curves classified by PVRecho tertiles were made and compared using log-rank tests to evaluate the influence of PVRecho on all-cause mortality and cardiac-related death.
Results
The median follow-up time was 579 days. Forty-one dogs with MMVD (PH severity [number]: no or mild, 21/33; moderate, 11/11; severe, 9/10) died during the study. In the multivariable Cox proportional hazard analysis adjusted for age, sildenafil administration, and American College of Veterinary Internal Medicine stage of MMVD, left atrial to aortic diameter ratio and PVRecho remained significant (adjusted hazard ratio [95% confidence interval]: 1.2 [1.1-1.3] and 2.1 [1.6-3.0], respectively). Higher PVRecho showed a significant association with lower survival rates. Conclusions and Clinical Importance Left atrial enlargement and high PVRecho were independent prognostic factors in dogs with MMVD and detectable tricuspid regurgitation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Laboratory of Veterinary Internal Medicine, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino-shi, Tokyo 180-8602, Japan.
ORCID profiles: Yunosuke Yuchi, Ryohei Suzuki, Takahiro Teshima
Funding
- Japan Society for the Promotion of Science
Cite
APA
Yuchi, Y., Suzuki, R., Yasumura, Y., Saito, T., Teshima, T., Matsumoto, H., & Koyama, H. (2023). Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16686
Vancouver
Yuchi Y, Suzuki R, Yasumura Y, Saito T, Teshima T, Matsumoto H, et al. Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16686
BibTeX
@article{Yuchi2023,
author = {Yuchi, Yunosuke and Suzuki, Ryohei and Yasumura, Yuyo and Saito, Takahiro and Teshima, Takahiro and Matsumoto, Hirotaka and Koyama, Hidekazu},
title = {Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension},
journal = {Journal of Veterinary Internal Medicine},
year = {2023},
doi = {10.1111/jvim.16686}
}
EUVIMED